Structure of the has operon promoter and the effect of mutations on the has promoter strength in Streptococcus equi subsp. zooepidemicus

Molecular Biotechnology

Volumn 49, Issue 2, 2011, Pages 166-175

  Krahulec, Ján ^a,b   Tlustá, Marcela ^a   Stuchlík, Stanislav ^b   Turňa, Ján ^b  

^a CPN Spol S Ro ^*  (Czech Republic)

^b Faculty of Natural Sciences   (Slovakia)

Author keywords

Has operon; Mutagenesis; Promoter; Streptococcus

Indexed keywords

HAS OPERON; NUCLEOTIDE MUTATION; NUCLEOTIDE SEQUENCES; PROMOTER; PROMOTER REGION; PROMOTER STRENGTH; START POINT; STREPTOCOCCUS; STREPTOCOCCUS PYOGENES; UPSTREAM REGION; ZOOEPIDEMICUS;

MUTAGENESIS; STRAIN; TRANSCRIPTION;

NUCLEOTIDES;

ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; GENE MUTATION; GENE STRUCTURE; HAS GENE; NONHUMAN; OPERON; PROMOTER REGION; STREPTOCOCCUS EQUI; GENETICS; MOLECULAR CLONING; MOLECULAR GENETICS; MUTAGENESIS; MUTATION; NUCLEOTIDE SEQUENCE; PLASMID; SEQUENCE ALIGNMENT; STREPTOCOCCUS PYOGENES;

STREPTOCOCCUS; STREPTOCOCCUS EQUI SUBSP. ZOOEPIDEMICUS; STREPTOCOCCUS PYOGENES;

BACTERIAL PROTEIN; BETA GLUCURONIDASE;

BACTERIAL PROTEINS; BASE SEQUENCE; CLONING, MOLECULAR; GENES, BACTERIAL; GLUCURONIDASE; MOLECULAR SEQUENCE DATA; MUTAGENESIS; MUTATION; OPERON; PLASMIDS; PROMOTER REGIONS, GENETIC; SEQUENCE ALIGNMENT; STREPTOCOCCUS EQUI; STREPTOCOCCUS PYOGENES;

EID: 84855983231     PISSN: 10736085     EISSN: 15590305     Source Type: Journal    
DOI: 10.1007/s12033-011-9388-4     Document Type: Article

References (34)

1. Meyer, K. (1934). The polysaccharide of the vitreous humor. Journal of Biological Chemistry, 107, 629-634.
2. Laurent, T. C., & Fraser, J. R. E. (1992). Hyaluronan. FASEB Journal, 6, 2397-2404.
3. Kendall, F., Heidelberger, M., & Dawson, M. (1937). A serologically inactive polysaccharide elaborated by mucoid strains of group A hemolytic streptococcus. Journal of Biological Chemistry, 118, 61-69.
4. Wessels, M. R., Moses, A. E., Goldberg, J. B., & DiCesare, T. J. (1991). Hyaluronic acid capsule is a virulence factor for mucoid group A streptococci. Proceedings of the National Academy of Sciences of the United States of America, 88, 8317-8321. (Pubitemid 21915347)
5. Carapetis, J., Robins-Browne, R., Martin, D., Shelby-James, T., & Hogg, G. (1995). Increasing severity of invasive group A streptococcal disease in Australia: Clinical and molecular epidemiological features and identification of a new virulent M-nontypeable clone. Clinical Infectious Diseases, 21, 1220-1227.
6. Chelsom, J., Halstensen, A., Tore, H., & Hoiby, E. A. (1994). Necrotising fasciitis due to group A streptococci in western Norway: Incidence and clinical features. Lancet, 344, 1111-1115. (Pubitemid 24317630)
7. Hoge, C. W., Schwartz, B., Talkington, D. F., Breiman, R. F., MacNeill, E. M., & Englender, S. J. (1993). The changing epidemiology of invasive group A streptococcal infections and the emergency of streptococcal toxic shock-like syndrome. JAMA, 269, 384-389. (Pubitemid 23018078)
8. Stevens, D. L., Tanner, M. H., Winship, J., Swarts, R., Ries, K. M., Schlievert, P. M., et al. (1989). Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. New England Journal of Medicine, 321, 1-8.
9. Johnson, D. R., Stevens, D. L., & Kaplan, E. L. (1992). Epidemiologic analysis of group A streptococcal serotypes associated with severe systemic infections, rheumatic fever, or uncomplicated pharyngitis. Journal of Infectious Diseases, 166, 374-382.
10. Moses, A. E., Wessels, M. R., Zalcman, K., Alberti, S., Natanson- Yaron, S., Menes, T., et al. (1997). Relative contributions of hyaluronic acid capsule and M protein to virulence in a mucoid strain of group A Streptococcus. Infection and Immunity, 65, 64-71. (Pubitemid 27008904)
11. Ji, Y., McLandsborough, L., Kondagunta, A., & Cleary, P. P. (1996). C5a peptidase alters clearance and trafficking of group A streptococci by infected mice. Infection and Immunity, 64(2), 503-510. (Pubitemid 26032821)
12. Crater, D. L., & van de Rijn, I. (1995). Hyaluronic acid synthesis operon (has) expression in group A streptococci. Journal of Biological Chemistry, 270, 18452-18458.
13. Wessels, M. R., Goldberg, J. B., Moses, A. E., & DiCesare, T. J. (1994). Effects on virulence of mutations in a locus essential for hyaluronic acid capsule expression in group A streptococci. Infection and Immunity, 62, 433-441. (Pubitemid 24033760)
14. DeAngelis, P. L., Papaconstantinou, J., & Weigel, P. H. (1993). Molecular cloning, identification, and sequence of the hyaluronan synthase gene from group A Streptococcus pyogenes. Journal of Biological Chemistry, 268, 19181-19184. (Pubitemid 23270683)
15. Dougherty, B. A., & van de Rijn, I. (1994). Molecular characterization of hasA from an operon required for hyaluronic acid synthesis in group A streptococci. Journal of Biological Chemistry, 269, 169-175. (Pubitemid 24026640)
16. Dougherty, B. A., & van de Rijn, I. (1993). Molecular characterization of hasB from an operon required for hyaluronic acid synthesis in group A streptococci. Journal of Biological Chemistry, 10, 7118-7124. (Pubitemid 23105599)
17. Alberti, S., Ashbaugh, C. D., & Wessels, M. R. (1998). Structure of the has operon promoter and regulation of hyaluronic acid capsule expression in group A Streptococcus. Molecular Microbiology, 28, 343-353. (Pubitemid 28182257)
18. McCure, P. M., & Wilson, W. D. (1989). Equine mastitis - a review of 28 cases. Equine Veterinary Journal, 21, 351-353.
19. Nimrod, A. (1998). Method of producing high molecular weight sodium hyaluronate by fermentation of streptococcus. US Patent 4,780,414.
20. Yamada, T., & Kawasaki, T. (2005). Microbial synthesis of hyaluronan and chitin: New approaches. Journal of Biosience and Bioengineering, 99(6), 521-528. (Pubitemid 41557160)
21. Chong, B. F., Blank, L. M., Mclaughlin, R., & Nielsen, L. K. (2005). Microbial hyaluronic acid production. Applied Microbiology and Biotechnology, 66, 341-351. (Pubitemid 40110137)
22. Blank, L. M., Hugenholtz, P., & Nielsen, L. K. (2008). Evolution of the hyaluronic acid synthesis (has) operon in Streptococcus zooepidemicus and other pathogenic streptococci. Journal of Molecular Evolution, 67, 13-22.
23. Ausubel, F. M., Brent, R., Kingston, R. E., Moore, D. D., Siedman, J. G., Smith, J. A., et al. (1987). Current protocols in molecular biology. New York: Wiley.
24. Bradford, M. M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry, 72, 248-254.
25. Husman, L. K., Yung, D. L., Hollingshead, S. K., & Scott, J. R. (1997). Role of putative virulence of Streptococcus pyogenes in mouse models of long-term throat colonization and pneumonia. Infection and Immunity, 65, 1422-1430. (Pubitemid 27146634)
26. Schrager, H. M., Rheinwald, J. G., & Wessels, M. R. (1996). Hyaluronic acid capsule and the role of streptococcal entry into keratinocytes in invasive skin infection. Journal of Clinical Investigation, 98, 1954-1958. (Pubitemid 26376281)
27. Wessels, M. R., & Bronze, M. S. (1994). Critical role of the group A streptococcal capsule in pharyngeal colonization and infection in mice. Proceedings of the National Academy of Sciences of the United States of America, 91, 12238-12242. (Pubitemid 24368640)
28. Hawley, D. K., & McClure, W. R. (1983). Compilation and analysis of Escherichia coli promoter DNA sequences. Nucleic Acids Research, 11(8), 2237-2255.
29. Kovacic, R. T. (1987). The 0 C closed complexes between Escherichia coli RNA polymerase and two promoters, T7-A3 and lacUV. Biological Chemistry, 262, 13654-13661.
30. Schickor, P., Metzger, W., Werel, W., Lederer, H., & Heumann, H. (1990). Topography of intermediates in transcription initiation in E. coli. EMBO Journal, 9, 2215-2220.
31. Grafe, S., Ellinger, T., & Malke, H. (1996). Structural dissection and functional analysis of the complex promoter of the streptokinase gene from Streptococcus equisimilis H46A. Medical Microbiology and Immunology, 185, 11-17. (Pubitemid 26177440)
32. McIver, K. S., Heath, A. S., Green, B. D., & Scott, J. R. (1995). Specific binding of the activator Mga to promoter sequences of the emm and scpA genes in the group A streptococcus. Journal of Bacteriology, 177, 6619-6624.
33. Morrison, D. A., & Jaurin, R. (1990). Streptococcus pneumoniae possesses canonical Escherichia coli (sigma 70) promoters. Molecular Microbiology, 4, 1143-1152.
34. Krahulec, J., & Krahulcová, J. (2007). Characterization of the new b-glucuronidase from Streptococcus equi subsp. zooepidemicus. Applied Microbiology and Biotechnology, 74(5), 1016-1022. (Pubitemid 46434753)